Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ARA / American Renal Associates Holdings, Inc. / Van Berkom & Associates Inc. - 13G AS OF DECEMBER 31, 2017 (Passive Investment)

2018-02-13 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) American Renal Associates Holdings, Inc. (ARA) -------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------- (Title of Class of Securities) 029227105 -------

ARA / American Renal Associates Holdings, Inc. / Van Berkom & Associates Inc. - 13G AS OF DECEMBER 31, 2017 (Passive Investment)

2018-02-13 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) American Renal Associates Holdings, Inc. (ARA) -------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------- (Title of Class of Securities) 029227105 -------

ARA / American Renal Associates Holdings, Inc. EXHIBIT 99.1

2018-02-01 sec.gov
Exhibit AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES SETTLEMENT OF SHAREHOLDER CLASS ACTION LITIGATION BEVERLY, MA (February 1, 2018) - American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that the Company has entered into a Stipulation of Settlement with the lead plaintiff in the shareholder class action lawsuit pending against it in the United States District Court for the District of Massachuse

ARA / American Renal Associates Holdings, Inc. 8-K (Current Report)

2018-02-01 sec.gov
Document   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 1, 2018  American Renal Associates Holdings, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-37751   27-2170749 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 5

ARA / American Renal Associates Holdings, Inc. 8-K (Current Report)

2018-01-25 sec.gov
Document   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 25, 2018  American Renal Associates Holdings, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-37751   27-2170749 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 5

ARA / American Renal Associates Holdings, Inc. EXHIBIT 10.1

2017-12-15 sec.gov
Exhibit Exhibit 10.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT This FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “First Amendment”) is entered into effective as of December 13, 2017 (the “First Amendment Effective Date”) by and among American Renal Management LLC, a Delaware limited liability company (the “Company”), and Jon Wilcox, a resident of the Commonwealth of Massachusetts (“Executive”). W I T N E S S E T H WHEREAS, the Company and Executive entered into that certain employment agreement,

ARA / American Renal Associates Holdings, Inc. 8-K (Current Report)

2017-12-15 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2017 American Renal Associates Holdings, Inc. (Exact name of registrant as specified in its charter)             Delaware   001-37751   27-2170749 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification Numbe

American Renal Associates Holdings 2017 Q3 - Results - Earnings Call Slides

2017-11-15 seekingalpha
The following slide deck was published by American Renal Associates Holdings in conjunction with their 2017 Q3 earnings call. (4-0)

American Renal Associates' (ARA) CEO Joe Carlucci on Q3 2017 Results - Earnings Call Transcript

2017-11-15 seekingalpha
Greetings, and welcome to the American Renal Associates Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (4-0)

ARA / American Renal Associates Holdings, Inc. EXHIBIT 99.1

2017-11-14 sec.gov
Exhibit AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES THIRD QUARTER 2017 RESULTS BEVERLY, MA (November 14, 2017) - American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced financial and operating results for the third quarter ended September 30, 2017. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See “Use of Non-GAAP Financial Measures” and the reconc

ARA / American Renal Associates Holdings, Inc. 8-K (Current Report)

2017-11-14 sec.gov
Document   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2017  American Renal Associates Holdings, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-37751   27-2170749 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification Number)

ARA / American Renal Associates Holdings, Inc. 10-Q (Quarterly Report)

2017-11-14 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 10-Q   ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from                  to                  Commission File Number 001-37751   American Renal Associates Holdings, Inc.

ARA / American Renal Associates Holdings, Inc. / FMR LLC / Fidelity Management & Research - 3G/A (Passive Investment)

2017-11-09 sec.gov
SCHEDULE 13G Amendment No. 2 AMERICAN RENAL ASOCS HLDGS INC COMMON STOCK Cusip #029227105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #029227105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 1,517,471 Item 8: 0 Item 9: 1,517,471 Item 11: 4.

ARA / American Renal Associates Holdings, Inc. / FMR LLC / Fidelity Management & Research - 3G/A (Passive Investment)

2017-11-09 sec.gov
SCHEDULE 13G Amendment No. 2 AMERICAN RENAL ASOCS HLDGS INC COMMON STOCK Cusip #029227105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #029227105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 1,517,471 Item 8: 0 Item 9: 1,517,471 Item 11: 4.

ARA / American Renal Associates Holdings, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-09 fintel.io
American Renal Associates Holdings, Inc. (NYSE:ARA) has 56 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,829,398 shares. Largest shareholders include Centerbridge Partners, L.P., FMR LLC / Fidelity Management & Research, Van Berkom & Associates Inc., TimesSquare Capital Management, LLC, and Vanguard Group Inc. (4-0)


CUSIP: 029227105